Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

NCT07296484 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

1500

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
Cortisol Excess

Interventions

DRUG: clofutriben
DRUG: Placebo

Sponsor

Sparrow Pharmaceuticals